Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis

por Boremalm, Malin, Sundström, Peter, Salzer, Jonatan
Publicado 2021

Inflammatory activity and vitamin D levels in an MS population treated with rituximab

por Linden, Johan, Granåsen, Gabriel, Salzer, Jonatan, Svenningsson, Anders, Sundström, Peter
Publicado 2019

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden

por Wickström, Anne, Sundström, Peter, Wickström, Lucas, Dahle, Charlotte, Vrethem, Magnus, Svenningsson, Anders
Publicado 2015

Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption

por Gröning, Remigius, Dernstedt, Andy, Ahlm, Clas, Normark, Johan, Sundström, Peter, Forsell, Mattias N. E.
Publicado 2023

Incidence and Prevalence of Multiple Sclerosis in Malmö, Southern Sweden

por Alonso-Magdalena, Lucía, Zia, Elisabet, Carmona i Codina, Olga, Pessah-Rasmussen, Hélène, Sundström, Peter
Publicado 2022

Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls

por de Flon, Pierre, Söderström, Lars, Laurell, Katarina, Dring, Ann, Sundström, Peter, Gunnarsson, Martin, Svenningsson, Anders
Publicado 2018

High serum concentration of vitamin D may protect against multiple sclerosis

por Biström, Martin, Alonso-Magdalena, Lucia, Andersen, Oluf, Jons, Daniel, Gunnarsson, Martin, Vrethem, Magnus, Hultdin, Johan, Sundström, Peter
Publicado 2019

Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis

por Jons, Daniel, Zetterberg, Henrik, Biström, Martin, Alonso‐Magdalena, Lucia, Gunnarsson, Martin, Vrethem, Magnus, Blennow, Kaj, Nilsson, Staffan, Sundström, Peter, Andersen, Oluf
Publicado 2022

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

por Novakova, Lenka, Zetterberg, Henrik, Sundström, Peter, Axelsson, Markus, Khademi, Mohsen, Gunnarsson, Martin, Malmeström, Clas, Svenningsson, Anders, Olsson, Tomas, Piehl, Fredrik, Blennow, Kaj, Lycke, Jan
Publicado 2017

Free vitamin D(3) index and vitamin D‐binding protein in multiple sclerosis: A presymptomatic case–control study

por Grut, Viktor, Biström, Martin, Salzer, Jonatan, Stridh, Pernilla, Lindam, Anna, Alonso‐Magdalena, Lucia, Andersen, Oluf, Jons, Daniel, Gunnarsson, Martin, Vrethem, Magnus, Hultdin, Johan, Sundström, Peter
Publicado 2022

Systemic inflammation and risk of multiple sclerosis – A presymptomatic case-control study

por Grut, Viktor, Biström, Martin, Salzer, Jonatan, Stridh, Pernilla, Lindam, Anna, Alonso-Magdalena, Lucia, Andersen, Oluf, Jons, Daniel, Gunnarsson, Martin, Vrethem, Magnus, Hultdin, Johan, Sundström, Peter
Publicado 2022

Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study

por Petersson, Malin, Feresiadou, Amalia, Jons, Daniel, Ilinca, Andreea, Lundin, Fredrik, Johansson, Rune, Budzianowska, Anna, Roos, Anna-Karin, Kågström, Viktor, Gunnarsson, Martin, Sundström, Peter, Piehl, Fredrik, Brauner, Susanna
Publicado 2021

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

por Salzer, Jonatan, Svenningsson, Rasmus, Alping, Peter, Novakova, Lenka, Björck, Anna, Fink, Katharina, Islam-Jakobsson, Protik, Malmeström, Clas, Axelsson, Markus, Vågberg, Mattias, Sundström, Peter, Lycke, Jan, Piehl, Fredrik, Svenningsson, Anders
Publicado 2016

Epstein–Barr virus infection after adolescence and human herpesvirus 6A as risk factors for multiple sclerosis

por Biström, M., Jons, D., Engdahl, E., Gustafsson, R., Huang, J., Brenner, N., Butt, J., Alonso‐Magdalena, L., Gunnarsson, M., Vrethem, M., Bender, N., Waterboer, T., Granåsen, G., Olsson, T., Kockum, I., Andersen, O., Fogdell‐Hahn, A., Sundström, Peter
Publicado 2020

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial

por Piehl, Fredrik, Eriksson-Dufva, Ann, Budzianowska, Anna, Feresiadou, Amalia, Hansson, William, Hietala, Max Albert, Håkansson, Irene, Johansson, Rune, Jons, Daniel, Kmezic, Ivan, Lindberg, Christopher, Lindh, Jonas, Lundin, Fredrik, Nygren, Ingela, Punga, Anna Rostedt, Press, Rayomand, Samuelsson, Kristin, Sundström, Peter, Wickberg, Oskar, Brauner, Susanna, Frisell, Thomas
Publicado 2022

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis

por Engdahl, Elin, Gustafsson, Rasmus, Huang, Jesse, Biström, Martin, Lima Bomfim, Izaura, Stridh, Pernilla, Khademi, Mohsen, Brenner, Nicole, Butt, Julia, Michel, Angelika, Jons, Daniel, Hortlund, Maria, Alonso-Magdalena, Lucia, Hedström, Anna Karin, Flamand, Louis, Ihira, Masaru, Yoshikawa, Tetsushi, Andersen, Oluf, Hillert, Jan, Alfredsson, Lars, Waterboer, Tim, Sundström, Peter, Olsson, Tomas, Kockum, Ingrid, Fogdell-Hahn, Anna
Publicado 2019